BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1618 related articles for article (PubMed ID: 24325907)

  • 1. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.
    Remely M; Aumueller E; Merold C; Dworzak S; Hippe B; Zanner J; Pointner A; Brath H; Haslberger AG
    Gene; 2014 Mar; 537(1):85-92. PubMed ID: 24325907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity.
    Remely M; Aumueller E; Jahn D; Hippe B; Brath H; Haslberger AG
    Benef Microbes; 2014 Mar; 5(1):33-43. PubMed ID: 24533976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecalibacterium prausnitzii phylotypes in type two diabetic, obese, and lean control subjects.
    Hippe B; Remely M; Aumueller E; Pointner A; Magnet U; Haslberger AG
    Benef Microbes; 2016 Sep; 7(4):511-7. PubMed ID: 27048834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of butyryl CoA:acetate CoA-transferase genes reveals different butyrate production capacity in individuals according to diet and age.
    Hippe B; Zwielehner J; Liszt K; Lassl C; Unger F; Haslberger AG
    FEMS Microbiol Lett; 2011 Mar; 316(2):130-5. PubMed ID: 21204931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and energy balance: role in obesity.
    Blaut M
    Proc Nutr Soc; 2015 Aug; 74(3):227-34. PubMed ID: 25518735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon.
    Christiansen CB; Gabe MBN; Svendsen B; Dragsted LO; Rosenkilde MM; Holst JJ
    Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G53-G65. PubMed ID: 29494208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes.
    Nøhr MK; Pedersen MH; Gille A; Egerod KL; Engelstoft MS; Husted AS; Sichlau RM; Grunddal KV; Poulsen SS; Han S; Jones RM; Offermanns S; Schwartz TW
    Endocrinology; 2013 Oct; 154(10):3552-64. PubMed ID: 23885020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids.
    Lukovac S; Belzer C; Pellis L; Keijser BJ; de Vos WM; Montijn RC; Roeselers G
    mBio; 2014 Aug; 5(4):. PubMed ID: 25118238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota of Obese, Type 2 Diabetic Individuals is Enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after Weight Loss.
    Remely M; Hippe B; Zanner J; Aumueller E; Brath H; Haslberger AG
    Endocr Metab Immune Disord Drug Targets; 2016; 16(2):99-106. PubMed ID: 27577947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal microbiota composition in vegetarians: comparison with omnivores in a cohort of young women in southern India.
    Kabeerdoss J; Devi RS; Mary RR; Ramakrishna BS
    Br J Nutr; 2012 Sep; 108(6):953-7. PubMed ID: 22182464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation.
    Kasubuchi M; Hasegawa S; Hiramatsu T; Ichimura A; Kimura I
    Nutrients; 2015 Apr; 7(4):2839-49. PubMed ID: 25875123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota composition correlates with changes in body fat content due to weight loss.
    Remely M; Tesar I; Hippe B; Gnauer S; Rust P; Haslberger AG
    Benef Microbes; 2015; 6(4):431-9. PubMed ID: 25609655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population.
    Fava F; Gitau R; Griffin BA; Gibson GR; Tuohy KM; Lovegrove JA
    Int J Obes (Lond); 2013 Feb; 37(2):216-23. PubMed ID: 22410962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin Sensitivity-Enhancing Activity of Phlorizin Is Associated with Lipopolysaccharide Decrease and Gut Microbiota Changes in Obese and Type 2 Diabetes (db/db) Mice.
    Mei X; Zhang X; Wang Z; Gao Z; Liu G; Hu H; Zou L; Li X
    J Agric Food Chem; 2016 Oct; 64(40):7502-7511. PubMed ID: 27635781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-chain fatty acid sensing in rat duodenum.
    Akiba Y; Inoue T; Kaji I; Higashiyama M; Narimatsu K; Iwamoto K; Watanabe M; Guth PH; Engel E; Kuwahara A; Kaunitz JD
    J Physiol; 2015 Feb; 593(3):585-99. PubMed ID: 25433076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics, prebiotics, synbiotics and insulin sensitivity.
    Kim YA; Keogh JB; Clifton PM
    Nutr Res Rev; 2018 Jun; 31(1):35-51. PubMed ID: 29037268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism.
    Xiao S; Zhang Z; Chen M; Zou J; Jiang S; Qian D; Duan J
    J Ethnopharmacol; 2019 Sep; 241():112032. PubMed ID: 31220598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
    Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
    Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals.
    Canfora EE; van der Beek CM; Hermes GDA; Goossens GH; Jocken JWE; Holst JJ; van Eijk HM; Venema K; Smidt H; Zoetendal EG; Dejong CHC; Lenaerts K; Blaak EE
    Gastroenterology; 2017 Jul; 153(1):87-97.e3. PubMed ID: 28396144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.